ORCHIDCHEM 
Orchid Chemicals & Pharmaceuticals Ltd
How do you think orchidchem will perform against the NIFTY? Pick this stock
CAPITAL4 COMMUNITY
All: Members who that have picked this stock: 60
58 outperforms
2 underperforms
Stars: Top Investors who have picked this stock: 9
9 outperforms
0 underperforms
CLASSIFICATION | SECTOR | INDUSTRY |
|---|---|---|
| Primary | Pharma & Healthcare | Pharmaceuticals |
SNAPSHOT
- BSE Code / NSE Ticker
- 524372 / ORCHIDCHEM
- Last traded time
- 2012-05-23 15:59:09
- Last traded on
- BSE
- Intra-day Low / High
- 117.4 / 124.1
- 52w closing Low / High
- 119.3 / 292.0
- Today Volume
- 2,898,530
- 30d avg Daily Volume
- 2,391,259
- Market Cap
- INR 840.5 cr
- P/E Ratio TTM
- 7.85
- Historical Performance
- Today
- Weekly
- Monthly
- 3 Months
- 1 Year
- -3.6%
- -6.2%
- -33.8%
- -33.6%
- -54.4%
valuation snapshotpeer comparisonfinancialsshare holdingmf holdingcommunity picksbrokerage picks futures & options
| Ticker | Audited | MCap | Total Assets | Net Sales | Adj PAT | Op Margin | Adj Net-Margin | ROCE | Adj P/E(TTM) | P/Book | Debt/MCap |
|---|---|---|---|---|---|---|---|---|---|---|---|
| UNICHEMLAB | 2011 | 1,190.2 | 708.5 | 760.8 | 106.6 | 14.2% | 14.0% | 22.6% | 14.4 | 1.8 | 0.0 |
| NATCOPHARM | 2011 | 1,187.7 | 566.8 | 344.6 | 52.2 | 16.8% | 15.1% | 16.7% | 19.1 | 3.4 | 0.2 |
| SOLVAYPHAR | 2010 | 1,081.5 | 165.9 | 294.7 | 50.9 | 24.0% | 17.3% | 45.7% | 20.0 | 6.5 | 0.0 |
| MERCK | 2010 | 964.1 | 346.4 | 509.1 | 63.1 | 11.7% | 12.4% | 27.8% | 18.2 | 2.8 | 0.0 |
| ORCHIDCHEM | 2011 | 840.5 | 2,979.3 | 1,663.3 | 159.0 | 9.8% | 9.6% | 12.2% | 7.9 | 0.7 | 2.2 |
| AJANTPHARM | 2011 | 715.2 | 373.8 | 457.2 | 46.4 | 15.6% | 10.2% | 18.9% | 10.8 | 3.3 | 0.2 |
| SHASUNPHAR | 2011 | 688.8 | 390.4 | 544.1 | 4.8 | -7.1% | 0.9% | 7.8% | 21.4 | 4.0 | 0.3 |
| SHILPAMED | 2011 | 668.0 | 286.2 | 257.6 | 50.9 | 26.3% | 19.8% | 24.0% | 15.4 | 2.8 | 0.1 |
| ELDERPHARM | 2011 | 656.5 | 1,359.8 | 832.4 | 70.8 | 12.7% | 8.5% | 11.7% | 7.2 | 1.1 | 1.1 |
| INDOCO | 2011 | 543.2 | 450.2 | 483.5 | 51.1 | 8.1% | 10.6% | 16.0% | 11.8 | 1.6 | 0.2 |
| JBCHEPHARM | 2011 | 539.5 | 881.8 | 784.5 | 121.2 | 14.1% | 15.4% | 17.2% | 10.0 | 0.8 | 0.3 |
| VINATIORGA | 2011 | 493.5 | 220.7 | 316.3 | 52.0 | 16.8% | 16.4% | 36.4% | 9.0 | 3.4 | 0.2 |
| NECLIFE | 2011 | 460.9 | 1,517.2 | 1,055.5 | 104.6 | 8.7% | 9.9% | 13.5% | 5.7 | 0.6 | 1.7 |
| SHARONBIO | 2011 | 439.3 | 542.3 | 606.1 | 31.3 | 6.0% | 5.2% | 12.3% | 11.1 | 2.2 | 0.8 |
CAPITAL4 COMMUNITY
STOCK SCREENERS
INDIA CAPITAL MARKETS
ORCHIDCHEM IN THE NEWS
- May-16 8:07 Orchid Chemicals & Pharmaceuticals net profit declines 66.47% in the March 2012 quarter
- May-08 12:39 Orchid Pharma receives USFDA approval for Naratriptan Tabs ANDA
- May-08 11:09 Orchid Chemicals & Pharmaceuticals to consider dividend
- Apr-05 9:25 Hon'ble High Court approves scheme of amalgamation of Orchid Chemicals & Pharmaceuticals
- Feb-08 15:00 Orchid Chemicals & Pharmaceuticals reports net loss of Rs 10.12 crore in the December 2011 quarter
- Feb-07 11:07 Orchid Chemicals & Pharmaceuticals receives USFDA approval
- Jan-11 9:56 Orchid Chemicals & Pharmaceuticals' board approves scheme of amalgamation
- Dec-30 16:28 Orchid Chemicals & Pharmaceuticals to hold board meeting
- Dec-23 11:28 Orchid's drug discovery research initiative with Merck advances anti-infective program meets preclinical milestone
TOP BLOGS
- Advice for – Tuesday, May 22, 2012
by ABHISHEK-PARAKH
(Recommendations: 6) - Money can be made in all market conditions
by ASHOKSHARMA
(Recommendations: 7) - The problem with historical returns
by ROHIT CHAUHAN
(Recommendations: 9) - Markets: What next?
by Nishit_Vadhavkar
(Recommendations: 8) - Nifty – RSI at sub 30. Highly Oversold – Bottoming out in next few sessions
by NOORESH MERANI
(Recommendations: 9) - Follow up: Gujarat reclaim & rubber products ltd
by ROHIT CHAUHAN
(Recommendations: 9) - Negative news drags the markets down
by Nishit_Vadhavkar
(Recommendations: 7) - Option strategy worked will in such unpredictable market
by ASHOKSHARMA
(Recommendations: 8) - Sensex- Technical Outlook and Trading Levels, 8 April 2012
by D_Sathiamoorthy
(Recommendations: 5) - Insourcing vs. outsourcing government functions: A setback for public sector production of elementary education
by AJAY SHAH
(Recommendations: 7) - Crucial Week Ahead
by Nishit_Vadhavkar
(Recommendations: 8) - A few contrarian thoughts
by ROHIT CHAUHAN
(Recommendations: 8)
Company and Mutual Fund Finder
| Company: | 3ABCDEFGHIJKLMNOPQRSTUVWXYZ |
| Indices: | NIFTY | SENSEX | BSE 100 | BSE 200 | BSE 500 | BSE MIDCAP | BSE SMALLCAP | BSE AUTO | BSE BANKEX | BSE CD | BSE CG | BSE FMCG | BSE HC | BSE IT | BSE METAL | BSE OIL | BSE POWER | BSE PSU | BSE REALTY | BSE TECK | BSE DOLLEX | DOLLEX 100 | DOLLEX 200 | NIFTY JUNIOR | CNX MIDCAP | NIFTY MID50 | BANK NIFTY | CNX IT | CNX100 | CNX 500 | CNX DEFTY |
| Mutual Funds: | AIG Global Investment | AXIS | Baroda Pioneer | Benchmark | Bharti AXA | Birla Sun Life | Canara Robeco | Deutsche | DSP BlackRock | Edelweiss | Escorts | Fidelity | Fortis | Franklin Templeton | HDFC | HSBC | ICICI Prudential | IDBI | IDFC | ING | JM Financial | JP Morgan | Kotak Mahindra | L&T | LIC | Mirae Asset | Morgan Stanley | Motilal Oswal | Peerless | Pramerica | PRINCIPAL | Quantum | Reliance | Religare | Sahara | SBI | Shinsei | Sundaram BNP Paribas | Tata | Taurus | UTI |